Filing Details

Accession Number:
0001144204-19-019115
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-10 18:39:56
Reporting Period:
2019-04-08
Accepted Time:
2019-04-10 18:39:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1464306 B. Stephen Howell 1330 Avenue Of The Americas,
33Rd Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-08 4,000 $7.77 79,494 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person has been delinquent in his Section 16 reporting and will file outstanding reports as soon as reasonably practicable. The amount reported in this Column 5 accounts for all prior transactions in the Issuer's common stock that have not been reported.